Abemaciclib, a CDK4 and CDK6 inhibitor for the treatment of...

  • Main
  • 2020 / 08
  • Abemaciclib, a CDK4 and CDK6 inhibitor for the treatment of...
Future Oncology 2020 / 08

Abemaciclib, a CDK4 and CDK6 inhibitor for the treatment of metastatic breast cancer

Martin, Miguel, Garcia-Saenz, Jose A, Manso, Luis, Llombart, Antonio, Cassinello, Alejo, Atienza, Manuel, Ringeisen, Francois, Ciruelos, Eva
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Future Oncology
DOI:
10.2217/fon-2020-0604
Date:
August, 2020
File:
PDF, 1.67 MB
2020
Conversion to is in progress
Conversion to is failed